Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Multiple Myeloma × darolutamide × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 39 Salivary Gland Neoplasms 3 Prostatic Neoplasms, Castration-Resistant 3 Neoplasms 3 Urogenital Neoplasms 2 Prostatic Diseases 2 Non-metastatic Castration-resistant Prostate Cancer 2 Neoplasm Metastasis 2 Metastatic Castration-resistant Prostate Cancer 2 Male Urogenital Diseases 2 Bulbo-Spinal Atrophy, X-Linked 2 Biochemically Recurrent Prostate Cancer 2 Adenocarcinoma 2 Urogenital Diseases 1 Triple Negative Breast Neoplasms 1 Sleep Initiation and Maintenance Disorders 1 Prostate Adenocarcinoma 1 Neoplasms by Site 1 Metastatic Castration-resistant Prostate Neoplasms 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 High-Risk Localized Prostate Cancer 1 Granulosa cell tumor of the ovary 1 Genital Diseases, Male 1 Fatigue 1 Depression 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Dexamethasone 221 Lenalidomide 138 daratumumab 118 Bortezomib 89 pomalidomide 79 Calcium Dobesilate 71 carfilzomib 68 Cyclophosphamide 65 Specimen Handling 37 Biopsy 37 belantamab mafodotin 36 fludarabine 33 isatuximab 31 Magnetic Resonance Spectroscopy 31 dexamethasone acetate 29 dexamethasone 21-phosphate 29 auricularum 28 Melphalan 28 talquetamab 27 ixazomib 24 iberdomide 22 elotuzumab 19 selinexor 17 fludarabine phosphate 16 Whole-Body Irradiation 12 X-Rays 11 Stem Cell Transplantation 11 tocilizumab 10 Standard of Care 10 venetoclax 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡